Fulminant Cardiac Hemochromatosis in a 48-Year-Old African Man With Homozygous TFR2 Variant: A Case Report
Canadian Journal of Cardiology · 2026-07
DOI: 10.1016/j.cjca.2026.07.010 ↗Kurz gefasst
Fallbericht in der Zeitschrift Canadian Journal of Cardiology, 2026-07. Verfasst von Soud Seif und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Aga Khan University Hospital, Nairobi, Kenya. Die Arbeit nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Aga Khan University Hospital, Nairobi, Kenya.
- Department of Hematology-Oncology, Aga Khan University Hospital, Nairobi, Kenya.
- Department of Medicine, Aga Khan University Hospital, Nairobi, Kenya. Electronic address: https://twitter.com/ngungamz.
- Department of Medicine, Aga Khan University Hospital, Nairobi, Kenya. Electronic address: https://twitter.com/DrJeilan.
- Department of Radiology, Aga Khan University Hospital, Nairobi, Kenya.
- Department of Medicine, Aga Khan University Hospital, Nairobi, Kenya. Electronic address: Etienne.amendezo@aku.edu.
Zitieren
APA
Seif, S., Kamadi, E., Kirui, L., Ngunga, M., Jeilan, M., Ombati, K., & Amendezo, E. (2026). Fulminant Cardiac Hemochromatosis in a 48-Year-Old African Man With Homozygous TFR2 Variant: A Case Report. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2026.07.010
Vancouver
Seif S, Kamadi E, Kirui L, Ngunga M, Jeilan M, Ombati K, et al. Fulminant Cardiac Hemochromatosis in a 48-Year-Old African Man With Homozygous TFR2 Variant: A Case Report. Canadian Journal of Cardiology. 2026. doi:10.1016/j.cjca.2026.07.010
BibTeX
@article{Seif2026,
author = {Seif, Soud and Kamadi, Effie and Kirui, Laura and Ngunga, Mzee and Jeilan, Mohamed and Ombati, Kevin and Amendezo, Etienne},
title = {Fulminant Cardiac Hemochromatosis in a 48-Year-Old African Man With Homozygous TFR2 Variant: A Case Report},
journal = {Canadian Journal of Cardiology},
year = {2026},
doi = {10.1016/j.cjca.2026.07.010}
}
EUVIMED